20/20 Biolabs, Inc. Common Stock (AIDX) is a publicly traded the market company. As of July 28, 2026, AIDX trades at $0.45 with a market cap of $6.02M and a P/E ratio of -1.62. AIDX moved -6.99% today. Year to date, AIDX is +0.00%; over the trailing twelve months it is flat. Its 52-week range spans $0.45 to $50.00. Analyst consensus is buy with an average price target of $5.00. Rallies surfaces AIDX's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
1 analysts cover AIDX: 0 strong buy, 1 buy, 0 hold, 0 sell, and 0 strong sell. The consensus rating is buy. The average price target is $5.00.
| Metric | Value |
|---|---|
| Price | $0.45 |
| Market Cap | $6.02M |
| P/E Ratio | -1.62 |
| EPS | $-0.28 |
| Dividend Yield | 0.00% |
| 52-Week High | $50.00 |
| 52-Week Low | $0.45 |
| Volume | 97.47K |
| Avg Volume | 0 |
| Revenue (TTM) | $353.38K |
| Net Income | $-2.17M |
| Gross Margin | 17.80% |
1 analysts cover AIDX: 0 strong buy, 1 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $5.00.